158 related articles for article (PubMed ID: 38173437)
41. Bioinformatics Analysis to Screen Key Targets of Curcumin against Colorectal Cancer and the Correlation with Tumor-Infiltrating Immune Cells.
Han X; Yang C; Guo C; Xu Y; Liu X; Xie R; Meng X; Cheng Z; Fu X
Evid Based Complement Alternat Med; 2021; 2021():9132608. PubMed ID: 34804186
[TBL] [Abstract][Full Text] [Related]
42. Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Cao J; Zhang R; Zhang Y; Wang Y
J Gastrointest Oncol; 2022 Feb; 13(1):311-325. PubMed ID: 35284134
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
44. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
[TBL] [Abstract][Full Text] [Related]
45. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
46. Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Sep; 234(9):15215-15224. PubMed ID: 30652311
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer.
Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701
[TBL] [Abstract][Full Text] [Related]
48. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
49. Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
Hameed Y; Usman M; Liang S; Ejaz S
PLoS One; 2021; 16(9):e0256020. PubMed ID: 34473751
[TBL] [Abstract][Full Text] [Related]
50. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
[No Abstract] [Full Text] [Related]
51. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
52. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.
Ashktorab H; Daremipouran M; Goel A; Varma S; Leavitt R; Sun X; Brim H
Epigenetics; 2014 Apr; 9(4):503-12. PubMed ID: 24441198
[TBL] [Abstract][Full Text] [Related]
53. Identification of key candidate genes for colorectal cancer by bioinformatics analysis.
Chen Z; Lin Y; Gao J; Lin S; Zheng Y; Liu Y; Chen SQ
Oncol Lett; 2019 Dec; 18(6):6583-6593. PubMed ID: 31788116
[TBL] [Abstract][Full Text] [Related]
54. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
55. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis.
Wang C; Zhang L
Medicine (Baltimore); 2022 Sep; 101(37):e30619. PubMed ID: 36123948
[TBL] [Abstract][Full Text] [Related]
56. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
57. Network Pharmacology and Molecular Docking-Based Investigation:
Zhou M; Li J; Luo D; Zhang H; Yu Z; Chen Y; Li Q; Liang F; Chen R
Front Pharmacol; 2021; 12():761980. PubMed ID: 34867383
[TBL] [Abstract][Full Text] [Related]
58. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
59. An age stratified analysis of the biomarkers in patients with colorectal cancer.
Yao H; Li C; Tan X
Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
[TBL] [Abstract][Full Text] [Related]
60. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
